TCRX · TScan Therapeutics, Inc. · Documents
$0.22
+0.00 (+0.00%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“However, substantial doubt about the Company's ability to continue as a going concern exists. ... These conditions raise substantial doubt about the Company's ability to continue as a going concern. ... Therefore, substantial doubt about the Company's ability to continue as a going concern has not been alleviated.”View the 10-Q filed Aug 12, 2026
Market Cap
$14.91M
Shares
67.78M
Volume · Oct 21
689.23K
Avg daily vol (3M)
771.87K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2022-05-09 | — | |
| DEF 14A | — | 2022-04-21 | 2022-06-01 | |
| DEFA14A | — | 2022-04-21 | — | |
| 8-K | — | 2022-03-09 | — | |
| 10-K | — | 2022-03-09 | 2021-12-31 | |
| 8-K | — | 2022-01-24 | — | |
| 8-K | — | 2021-12-02 | — | |
| 8-K | — | 2021-11-10 | — | |
| 10-Q | — | 2021-11-10 | 2021-09-30 | |
| 8-K | — | 2021-08-19 | — | |
| 10-Q | — | 2021-08-19 | 2021-06-30 | |
| 8-K | — | 2021-07-20 | 2021-07-15 | |
| S-1/A | — | 2021-07-12 | — | |
| S-1/A | — | 2021-05-14 | — | |
| S-1/A | — | 2021-05-05 | — | |
| S-1/A | — | 2021-04-30 | — | |
| S-1 | — | 2021-04-23 | — |
Showing 101–117 of 117 filings